Logo-NPhU new year

The pharmaceutical industry is recognized as one of the main engines of the economy EU

The pharmaceutical industry is a key factor in the economy of European countries. This is stated in a research report, “Economic Impact of a number of pharmaceutical companies in Europe”, prepared by an independent research institute WifOR the assistance of the European Federation of Pharmaceutical Industry and Associations (EFPIA), transmits Remedyum.
We consider the economic impact and contribution to the EU economy in the years 2010-2014 the seven producers of drugs: Abbvie, AstraZeneca, Boehringer Ingelheim, Ipsen, J & J, Novartis and Sanofi.
In 2014, seven companies considered in the total accounts brought to the GDP of the European Union 77.9 billion euros. The report emphasizes that the activities of pharmaceutical manufacturers provide about 865 thousand. Jobs. Of these, a little over 153 thousand. Man working directly in the pharmaceutical industry, while the remaining 711.6 thousand. Workers employed in related fields.
Experts note that although the purpose of the European Commission is to increase funding for research and development to 3% of GDP by 2020, the company Abbvie, AstraZeneca, Boehringer Ingelheim, Ipsen, J & J, Novartis and Sanofi largely already exceeded this figure. All of the company’s average reinvest in the development of new drugs for about 17.4% of their income.